NCT07673562 The Value of a Simple Tool for the Early Detection of Decompensated Heart Failure in People Over 55 on Réunion Island: A Preliminary Study in Hospitals (DEPIST'IC-RUN)
| NCT ID | NCT07673562 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de la Réunion |
| Condition | Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2027-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-08-01 with a primary completion date of 2027-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to assess the discriminatory power of a previously developed tool for detecting decompensated heart failure-which includes, in particular, clinical signs-in a population of patients hospitalized in cardiology units in Réunion. The main question it aims to answer is : Would a simple and rapid screening tool for decompensated heart failure help identify a high probability of this condition in a population hospitalized in a cardiology unit in Réunion? This study includes patients aged 55 and older, who reside in Réunion, who were admitted on an unscheduled basis to the cardiology department at the Réunion University Hospital or the Ouest Réunion Hospital, for any reason (whether as an inpatient or in the intensive care unit) The study is conducted in two phases: Phase 1: Development of the new e-DELPHI consensus-based screening tool Phase 2: Administration of the Déspist'IC-Run early detection tool for decompensated heart failure and performance of the gold standard cardiology examination (RIPH3)
Eligibility Criteria
Inclusion Criteria: Patients: * Aged 55 and older * Admitted on an unscheduled basis to the cardiology department at the CHU (North and South campuses) and the CHOR for any reason (in general wards or intensive care) * Residents of Réunion * Able to read and write French * Enrolled in a social security program * Willing to participate in the study Exclusion Criteria: Patients: * Who cannot communicate in French * For whom it is impossible to administer the questionnaire * For whom the ETT and/or cardiology consultation are impossible * Who are under guardianship, conservatorship, or judicial protection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07673562 clinical trial?
This trial is open to participants of all sexes, aged 55 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07673562 currently recruiting?
Yes, NCT07673562 is actively recruiting participants. Contact the research team at jerome.corre@chu-reunion.fr for enrollment information.
Where is the NCT07673562 trial being conducted?
This trial is being conducted at Saint-Denis, Reunion, Saint-Paul, Reunion, Saint-Pierre, Reunion.
Who is sponsoring the NCT07673562 clinical trial?
NCT07673562 is sponsored by Centre Hospitalier Universitaire de la Réunion. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.